Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease

Abstract Pompe disease is a metabolic myopathy due to acid alpha‐glucosidase deficiency. In addition to glycogen storage, secondary dysregulation of cellular functions, such as autophagy and oxidative stress, contributes to the disease pathophysiology. We have tested whether oxidative stress impacts...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonietta Tarallo, Carla Damiano, Sandra Strollo, Nadia Minopoli, Alessia Indrieri, Elena Polishchuk, Francesca Zappa, Edoardo Nusco, Simona Fecarotta, Caterina Porto, Marcella Coletta, Roberta Iacono, Marco Moracci, Roman Polishchuk, Diego Luis Medina, Paola Imbimbo, Daria Maria Monti, Maria Antonietta De Matteis, Giancarlo Parenti
Format: article
Language:EN
Published: Wiley 2021
Subjects:
alpha‐glucosidase
enzyme replacement therapy
N‐acetylcysteine
oxidative stress
Pompe disease
Medicine (General)
R5-920
Genetics
QH426-470
Online Access:https://doaj.org/article/c9d76b1dfda5478da27f60239b67fa37
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/c9d76b1dfda5478da27f60239b67fa37

Similar Items